Amphastar Pharmaceuticals (AMPH) Inventory Average (2014 - 2026)

Amphastar Pharmaceuticals' Inventory Average history runs 13 years deep, the most recent figure standing at $173.5 million for Q1 2026.

• In Q1 2026, Inventory Average rose 2.32% year-over-year to $173.5 million; the TTM figure through Mar 2026 stood at $173.5 million (up 2.32% YoY), while the FY2025 annual figure was $165.3 million, up 27.37% from the prior year.
• Inventory Average was $173.5 million for Q1 2026 at Amphastar Pharmaceuticals, down from $181.4 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $188.8 million in Q3 2025 to a low of $94.0 million in Q1 2022.
• Historically, Inventory Average has averaged $130.5 million across 5 years, with a median of $110.7 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Inventory Average retreated 3.09% in 2022, then surged 58.55% in 2025.
• A 5-year view of Inventory Average shows it stood at $103.4 million in 2022, then gained by 4.34% to $107.9 million in 2023, then soared by 31.62% to $142.0 million in 2024, then grew by 27.73% to $181.4 million in 2025, then retreated by 4.34% to $173.5 million in 2026.
• The last three Inventory Average figures came in at $173.5 million (Q1 2026), $181.4 million (Q4 2025), and $188.8 million (Q3 2025), per Business Quant data.